Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant p...
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer
About this item
Full title
Author / Creator
Bracarda, Sergio , Gernone, Angela , Gasparro, Donatello , Marchetti, Paolo , Gianni, Luca , Bortolus, Roberto , Fratino, Lucia , Zagonel, Vittorina , Mazzanti, Roberto , Messina, Caterina , Tucci, Marcello , Boccardo, Francesco , Cartenì, Giacomo , Pinto, Carmine , Fornarini, Giuseppe , Mattioli, Rodolfo , Procopio, Giuseppe , Chiuri, Vincenzo , Scotto, Tiziana , Dondi, Davide and Di Lorenzo, Giuseppe
Publisher
England: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Cabazitaxel is a novel taxane that is approved for use in metastatic castration-resistant prostate cancer based on the Phase III TROPIC study, which showed improved overall survival with cabazitaxel/prednisone versus mitoxantrone/prednisone. A global early-access program was initiated in order to provide early access to cabazitaxel in docetaxel-pre...
Alternative Titles
Full title
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer
Authors, Artists and Contributors
Author / Creator
Gernone, Angela
Gasparro, Donatello
Marchetti, Paolo
Gianni, Luca
Bortolus, Roberto
Fratino, Lucia
Zagonel, Vittorina
Mazzanti, Roberto
Messina, Caterina
Tucci, Marcello
Boccardo, Francesco
Cartenì, Giacomo
Pinto, Carmine
Fornarini, Giuseppe
Mattioli, Rodolfo
Procopio, Giuseppe
Chiuri, Vincenzo
Scotto, Tiziana
Dondi, Davide
Di Lorenzo, Giuseppe
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1537597717
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1537597717
Other Identifiers
ISSN
1479-6694
E-ISSN
1744-8301
DOI
10.2217/fon.13.256
